About James Schoeneck
James Schoeneck is a director at Calidi Biotherapeutics.
James Schoeneck reports to the SEC as a director or officer of 5 public companies, including Kyntra Bio (KYNB), Connect Biopharma Holdings (CNTB) and Anaptysbio (ANAB).
James Schoeneck first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name James Schoeneck in the role, so the role may have started earlier or lasted longer.
KI
Kyntra Bio, Inc.
Interim President and director
2014 – 2026 · Public company (KYNB)
CL
Connect Biopharma Holdings Ltd
Director
2026 · Public company (CNTB)
AI
Anaptysbio, Inc.
Director
2017 – 2018 · Public company (ANAB)
AI
Assertio Therapeutics, Inc
President and CEO, director
2007 – 2017 · Public company (ASRT)
Key Colleagues at Startups
The people James Schoeneck works with at each company, as listed on that company's latest Form D.
Calidi Biotherapeutics, Inc. · Form D, Jun 29, 2023
AC
Allan Camaisa
CEO and director
HL
Heehyoung Lee
Director
AZ
Alfonso Zulueta
Director
AS
Anthony Santidrian
Executive officer
BM
Boris Minev
Interim Chief Medical Officer
ST
Stephen Thesing
Chief Business Officer
TK
Tony Kalajian
Interim Chief Financial Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director
GN
George Ng
Director